Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.8295 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.80418 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.7376 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.73831 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.28075 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.9567 | 65 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.8331 | 63 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.81281 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.80517 | 64 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.85638 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.82066 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.82175 | 64 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.82586 | 64 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.82425 | 64 |